ASTRAZENECA AB - Sweden 

This institution has been merged with: ASTRAZENECA.

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:900-1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:68
Total Project Funding:500-600
Partner Constancy:51
Project Leadership Index:69
Diversity Index:64
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:70
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:800-900
Total Number of Projects:900-1000
Total Project Funding:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:400-500
2010
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:600-700
Total Number of Projects:800-900
Total Project Funding:500-600
Networking Rank (Reputation):700-800
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2009
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:800-900
2008
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Total Project Funding:300-400
Networking Rank (Reputation):500-600
Partner Constancy:400-500
Project Leadership Index:> 1000
Diversity Index:200-300
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 32
As coordinator: 0
As participant: 32
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 18.249.993 0 1
2017 0 66.648.068 527.319 7
2016 0 37.769.192 2.021.388 9
2015 0 10.088.161 666.784 3
2014 0 3.301.294 232.272 1
2013 0 21.428.778 2.163.015 6
2012 0 4.165.299 202.078 1
2011 0 8.609.001 473.035 2
2010 0 5.791.918 364.670 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE7
JANSSEN PHARMACEUTICA NV7
ELI LILLY AND COMPANY LIMITED5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
UNIVERSITAET BERN5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
GOETEBORGS UNIVERSITET4
KAROLINSKA INSTITUTE4
NOVARTIS PHARMA4
PFIZER LIMITED4
SANOFIAVENTIS DEUTSCHLAND4
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
F HOFFMANNLA ROCHE3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT3
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE3
UNIVERSITEIT LEIDEN3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UPPSALA UNIVERSITET3
ABBVIE DEUTSCHLAND GMBH & CO KG2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS LEIDEN2
ALZHEIMER EUROPE2
BAYER AKTIENGESELLSCHAFT2
CERTARA UK LIMITED2
CHALMERS TEKNISKA HOEGSKOLA AB2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ENAMINE LIMITED LIABILITY COMPANYRESEARCH AND PRODUCTION ENTERPRISE2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EUROPEAN SYNCHROTRON RADIATION FACILITY2
GIOTTO BIOTECH2
GLAXOSMITHKLINE BIOLOGICALS2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTET2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LEAD DISCOVERY CENTER2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE2
ORION OYJ2
RIJKSUNIVERSITEIT GRONINGEN2
SANOFI PASTEUR2
SP SWEDISH NATIONAL TESTING AND RESEARCH INSTITUTE2
STICHTING VUMC2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAROS CHEMICALS GMBH & CO KG2
TECHNISCHE UNIVERSITAET MUENCHEN2
TECHNISCHE UNIVERSITEIT EINDHOVEN2
THE UNIVERSITY OF SHEFFIELD2
UCB BIOPHARMA SPRL2
UCB PHARMA2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITAET HAMBURG2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAT WIEN2
UNIVERSITE DE BORDEAUX2
UNIVERSITE VICTOR SEGALEN BORDEAUX II2
UNIVERSITEIT ANTWERPEN2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF LEEDS2
UNIWERSYTET JAGIELLONSKI2
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER2
AALTO KORKEAKOULUSAATIO SR1
AARHUS UNIVERSITETSHOSPITAL1
ABBVIE1
ABBVIE1
ABBVIE INC1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACTELION PHARMACEUTICALS1
ALLERGAN LIMITED1
ALMAC DIAGNOSTICS LIMITED1
ALZECURE DISCOVERY1
ALZHEIMER'S RESEARCH UK1
AMGEN LIMITED1
ANANAS NANOTECH1
ANTAROS MEDICAL AB1
ARTTIC1
ASDM CONSULTING1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS1
ASTELLAS PHARMA EUROPE BV1
ASTEX1
AVANTEA1
AXON NEUROSCIENCE SE1

Constancy:

Total number of partners: 477
Partner loyalty:
Frequent Partner: (> 2 projects): 105
Rare Partner: 372
Frequent / Rare Partner Ratio: 0.28

Project overview:

Start dateProjectacronymrolefundingpartners
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-09-01Improving Genome Editing Efficiency (IMGENE) IMGENEparticipant2.068.40910
2017-01-01Molecular Tools for Nucleic Acid Manipulation for Biological Intervention MMBioparticipant3.971.34819
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-10-01Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 MOPEADparticipant2.043.00015
2016-06-01PET Imaging in Drug Design and Development PET3Dparticipant3.901.24810
2016-02-01Targeted small-molecule Stabilisation of Protein-Protein Interactions TASPPIparticipant3.342.32312
2016-01-01ISOTOPIC LABELING FOR DRUG INNOVATION ISOTOPICSparticipant3.948.84413
2016-01-01Non-Noble Metal Catalysis - NoNoMeCat NoNoMeCatparticipant3.318.63415
2016-01-01Big Data in Chemistry BIGCHEMparticipant2.540.14617
2016-01-01Accelerated Early staGe drug diScovery AEGISparticipant3.836.99626
2015-11-01Synaptic Dysfunction in Alzheimer Disease SyDADparticipant3.846.73611
2015-09-01Exascale Compound Activity Prediction Engine ExCAPEparticipant3.910.1409
2015-01-01Advanced XFEL and Synchrotron based Probes of Protein Structure and Dynamics X-probeparticipant2.331.2859
2014-03-01"FLUOR21 : Synthesis, structure and function of fluorinated systems" FLUOR21participant3.301.2949
2013-10-01Phylogenetic exploration of medicinal plant diversity MEDPLANTparticipant4.231.60510
2013-10-01Female Investigators in Nonlinear Optical Nanoscopy - FINON FINONparticipant3.470.6526
2013-10-01Identification and validation of novel pharmaceutical drug targets for cardiovascular disease CARTARDISparticipant5.973.52113
2013-01-01Membrane Protein Nanocrystallography NANOMEMparticipant2.814.62910
2013-01-01Innovative Modelling for Pharmacological Advances through Collaborative Training IMPACTparticipant1.467.9582
2013-01-01Pushing the Envelope of Nuclear Magnetic Resonance Spectroscopy for Paramagnetic Systems. A Combined Experimental and Theoretical Approach PNMRparticipant3.470.41312
2012-01-01Development of Cytochrome P450 Enzymes for the Chemical Manufacturing Industries P4FIFTYparticipant4.165.29910
2011-03-01Integrating research training in particle & powder technology to deliver efficient products with high functionality PowTechparticipant3.909.00115
2011-01-01Stem Cells for Relevant Efficient Extended and Normalized Toxicology SCR&TOXparticipant4.700.00015
2010-11-01Pulmonary Imaging Network π-netparticipant3.043.59910
2010-01-01Arrhythmogenic potential of drugs ARITMOparticipant2.748.31920